Literature DB >> 11238876

JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

I J Koralnik1, R A Du Pasquier, N L Letvin.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by a reactivation of the polyomavirus JC (JCV) within a setting of immunosuppression. The nature of the immune response that contains replication of this virus is unknown. We have explored JCV-specific cellular immune responses in patients with PML and control subjects. JCV antigen-stimulated peripheral blood mononuclear cells (PBMC) of four human immunodeficiency virus (HIV)-infected patients who were survivors of PML and one HIV-uninfected patient recently diagnosed with PML lysed autologous B-lymphoblastoid cell lines expressing either the JCV T regulatory protein or the VP1 major capsid protein. This lysis was mediated by CD8(+) T lymphocytes and was major histocompatibility complex class I restricted. These cells were therefore cytotoxic T lymphocytes (CTL). JCV-specific CTL could not be detected in PBMC of three HIV-infected PML patients who had progressive neurologic disease and an eventual fatal outcome. These data suggest that the JCV-specific cellular immune response may play a crucial role in the containment of PML. This finding may also prove useful as a favorable prognostic marker in the clinical management of these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238876      PMCID: PMC114143          DOI: 10.1128/JVI.75.7.3483-3487.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Progressive multifocal leukoencephalopathy: failure of response to transfer factor and cytarabine.

Authors:  G V Horn; F O Bastian; J L Moake
Journal:  Neurology       Date:  1978-08       Impact factor: 9.910

2.  Progressive multifocal leucoencephalopathy: remission with cytarabine.

Authors:  P J Marriott; M D O'Brien; I C Mackenzie; I Janota
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-03       Impact factor: 10.154

3.  Multiple central nervous system infections in progressive multifocal leukoencephalopathy.

Authors:  T Mathews; H Wisotzkey; J Moossy
Journal:  Neurology       Date:  1976-01       Impact factor: 9.910

4.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; R J Eckroade; B H Dessel
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

5.  "Spontaneous" progressive multifocal leukoencephalopathy. Immunologic aspects.

Authors:  A Knight; P O'Brien; D Osoba
Journal:  Ann Intern Med       Date:  1972-08       Impact factor: 25.391

6.  The epidemiology of human polyomaviruses.

Authors:  D L Walker; B L Padgett
Journal:  Prog Clin Biol Res       Date:  1983

7.  Molecular genetics of vaccinia virus: demonstration of marker rescue.

Authors:  E Nakano; D Panicali; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus.

Authors:  E Willoughby; R W Price; B L Padgett; D L Walker; B Dupont
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

9.  Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.

Authors:  G L Smith; B R Murphy; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

10.  Human polyomavirus in pregnancy. A model for the study of defence mechanisms to virus reactivation.

Authors:  D V Coleman; S D Gardner; C Mulholland; V Fridiksdottir; A A Porter; R Lilford; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

View more
  48 in total

1.  The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

Authors:  P Cinque; C Pierotti; M G Viganò; A Bestetti; C Fausti; D Bertelli; A Lazzarin
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 2.  Designs for clinical trials to test the efficacy of therapeutics in progressive multifocal leukoencephalopathy.

Authors:  C T Yiannoutsos; A De Luca
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

3.  Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?

Authors:  Renaud A Du Pasquier; Igor J Koralnik
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

4.  JC Virus Infection After Transplantation: Beyond the Classic Progressive Multifocal Leukoencephalopathy?

Authors:  Supha Kijpittayarit; Raymund R Razonable
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-01

Review 5.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

Review 6.  Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.

Authors:  Martyn K White; Ilker K Sariyer; Jennifer Gordon; Serena Delbue; Valeria Pietropaolo; Joseph R Berger; Kamel Khalili
Journal:  Rev Med Virol       Date:  2015-12-14       Impact factor: 6.989

7.  Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells.

Authors:  Christian Wüthrich; Santosh Kesari; Woong-Ki Kim; Kenneth Williams; Rebecca Gelman; Derek Elmeric; Umberto De Girolami; Jeffrey T Joseph; Tessa Hedley-Whyte; Igor J Koralnik
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

8.  Case 15: when a stroke is not a stroke.

Authors:  W Bryan Burnette
Journal:  MedGenMed       Date:  2007-01-30

Review 9.  Progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

10.  Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.

Authors:  R A Du Pasquier; J E Schmitz; J Jean-Jacques; Y Zheng; J Gordon; K Khalili; N L Letvin; I J Koralnik
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.